Ohio Doc Defaults on DEA Fight, Loses Drug-Prescribing Power
Published Date: 9/29/2026
Notice
Summary
Dr. Christopher Nadorff from Ohio lost his DEA registration because he no longer has permission to handle controlled substances in his state. He didn’t ask for a hearing, so the DEA canceled his registration by default. This means he can’t legally prescribe or manage controlled drugs anymore, effective immediately.
Analyzed Economic Effects
3 provisions identified: 1 benefits, 2 costs, 0 mixed.
DEA Registration Revoked for Dr. Nadorff
Dr. Christopher Nadorff’s DEA Certificate of Registration No. FN4962761 is revoked. The Order says his Ohio medical license was suspended effective October 8, 2025, and the DEA revocation is effective October 29, 2026, so he is no longer authorized to prescribe, administer, or dispense controlled substances in Ohio.
Pending DEA Renewal/Modification Applications Denied
The DEA denied any pending applications by Christopher Nadorff, M.D., to renew or modify Certificate No. FN4962761 and denied any other pending application for additional registration in Ohio. That denial is effective with the Order on October 29, 2026.
Opportunity to File Reconsideration Motion
The Order notes that Dr. Nadorff may file a properly supported motion for reconsideration of the Agency's factual finding that he is not licensed in Ohio. Any such motion must be filed within fifteen calendar days of the date of the Order and served by email as specified in the Order.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11526, Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128, Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2025-02793, Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients
The government is giving veterans easier access to buprenorphine treatment through telemedicine, letting them get care remotely. This change affects veterans using VA health services and aims to make treatment smoother and more convenient. The new rules were supposed to start February 18, 2025, but now they’ll kick in on March 21, 2025, while the government gathers public feedback.
2026-19842, JT Medical, LLC; Decision and Order
JT Medical, LLC tried to get a DEA registration to handle marijuana but didn’t meet the rules because they couldn’t prove they had a real supply deal or a secure storage cabinet. Since they didn’t respond to the government’s concerns on time, their application was denied. This means JT Medical can’t legally handle marijuana products, and anyone working with them should look for other options.
2026-19821, Johann Farley, M.D.; Decision and Order
Dr. Johann Farley from Indiana lost his DEA registration because he was kicked out of Medicare, Medicaid, and other federal health programs. This means he can no longer legally handle controlled substances starting September 30, 2025. The DEA made this decision official in 2026 to keep healthcare and drug laws strong and clear for everyone.
2026-19839, Jorge J. Figueroa, M.D.; Decision and Order
Dr. Jorge J. Figueroa from New Jersey lost his DEA registration because he was kicked out of Medicare, Medicaid, and other federal health programs. He didn’t ask for a hearing, so the DEA made the decision official. This means he can’t legally handle controlled substances anymore, effective immediately, impacting his medical practice and income.
Previous / Next Documents
Previous: 2026-19839, Jorge J. Figueroa, M.D.; Decision and Order
Dr. Jorge J. Figueroa from New Jersey lost his DEA registration because he was kicked out of Medicare, Medicaid, and other federal health programs. He didn’t ask for a hearing, so the DEA made the decision official. This means he can’t legally handle controlled substances anymore, effective immediately, impacting his medical practice and income.
Next: 2026-19841, Inflation Adjustment for EOIR OBBBA Fees for Certain DHS Forms; Fiscal Year 2027
Starting October 1, 2026, the Department of Justice is raising fees for certain immigration forms filed with the Executive Office for Immigration Review to keep up with inflation. This affects folks using forms like I-485, I-589, I-601, and I-821. The fee changes help cover costs but don’t affect other DHS fees, so get ready for a small price bump next fiscal year!